A 28-year-old male farmer from rural Maharashtra presents to the emergency department with a 10-day history of fever, headache, and progressive behavioral changes. He reports that 6 weeks ago, he was bitten by a stray dog while working in his field; the wound was washed with soap and water but he did not seek medical attention. Over the past 3 days, he has developed hydrophobia, hypersalivation, and episodes of aggression alternating with periods of lethargy. On examination, he is febrile (38.5°C), confused, and shows signs of autonomic instability with fluctuating heart rate and blood pressure. CSF analysis shows lymphocytic pleocytosis with normal glucose and protein. What is the most appropriate immediate management?

Explanation

## Clinical Context This patient presents with classic **furious (encephalitic) rabies** — a 6-week incubation period following a dog bite, prodromal fever/headache, and pathognomonic signs of hydrophobia, hypersalivation, autonomic instability, and alternating agitation with lethargy. CSF lymphocytic pleocytosis with normal or mildly elevated glucose/protein is consistent with viral encephalitis; in rabies, CSF is often near-normal or shows only mild changes. ## Why the Milwaukee Protocol is the Answer **Key Point:** Once clinical rabies develops (symptomatic disease), the case fatality rate approaches **100%** with supportive care alone. The **Milwaukee Protocol** is the only intervention that has achieved documented survival in clinical rabies encephalitis, making it the most appropriate aggressive management in a resource-rich setting. **High-Yield:** The Milwaukee Protocol involves: 1. Induction of **therapeutic coma** with midazolam and ketamine (to reduce excitotoxic neuronal damage) 2. High-dose antivirals — **ribavirin** and **amantadine** (acyclovir has no efficacy against rabies, a rhabdovirus) 3. Supportive ICU care with mechanical ventilation 4. Immunotherapy (interferon-alpha, intrathecal ribavirin — experimental components) **Clinical Pearl:** Survival with the Milwaukee Protocol remains **rare (<5% in most series)**, and the protocol is considered experimental. It is not universally adopted in resource-limited settings such as India, where palliative/comfort care is often the realistic standard. However, for examination purposes (NEET PG / INI-CET), the Milwaukee Protocol is the recognized answer for "most appropriate management of established clinical rabies" in a patient who presents to a facility capable of ICU care. ## Why Other Options Are Wrong | Option | Why Incorrect | |--------|---------------| | **Lumbar puncture + defer treatment** | Rabies virus is rarely isolated from CSF; culture takes weeks. Delaying intervention while awaiting results is inappropriate once clinical rabies is established. | | **High-dose IV acyclovir alone** | Acyclovir targets HSV (a herpesvirus) via thymidine kinase. Rabies is a **rhabdovirus** with no thymidine kinase; acyclovir monotherapy has no efficacy and would be used only if HSV encephalitis were the diagnosis. | | **RIG + rabies vaccine (PEP)** | Post-exposure prophylaxis is effective **only before symptom onset**. Once clinical rabies develops, the virus has invaded the CNS; RIG cannot cross the blood-brain barrier effectively. Administering PEP after symptom onset is **contraindicated** and wastes critical time. | ## Supporting Evidence **High-Yield:** The Milwaukee Protocol produced the first documented long-term survivor of clinical rabies without prior vaccination — Jeanna Giese in 2004. Subsequent application has yielded very few survivors (<5% in specialized centers), and the protocol remains experimental. In India, WHO and NHP guidelines emphasize that once clinical rabies is established, management is largely supportive/palliative; however, the Milwaukee Protocol remains the **only evidence-based aggressive intervention** cited in Harrison's Principles of Internal Medicine (21e, Ch. 196) for symptomatic rabies. **Reference:** Harrison's Principles of Internal Medicine, 21st edition, Chapter 196 (Rabies and Other Rhabdovirus Infections); KD Tripathi Essentials of Medical Pharmacology, 8th edition.